LeMaitre Vascular, Inc. (LMAT)
80.01
+0.05
(+0.06%)
USD |
NASDAQ |
Aug 25, 12:18
LeMaitre Vascular EPS Diluted (Quarterly) : 0.695 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.695 |
| March 31, 2026 | 0.6808 |
| December 31, 2025 | 0.6784 |
| September 30, 2025 | 0.7528 |
| June 30, 2025 | 0.6019 |
| March 31, 2025 | 0.4808 |
| December 31, 2024 | 0.4883 |
| September 30, 2024 | 0.4879 |
| June 30, 2024 | 0.5204 |
| March 31, 2024 | 0.4381 |
| December 31, 2023 | 0.3769 |
| September 30, 2023 | 0.3337 |
| June 30, 2023 | 0.3607 |
| March 31, 2023 | 0.2712 |
| December 31, 2022 | 0.253 |
| September 30, 2022 | 0.2456 |
| June 30, 2022 | 0.1588 |
| March 31, 2022 | 0.2732 |
| December 31, 2021 | 0.2789 |
| September 30, 2021 | 0.2965 |
| June 30, 2021 | 0.396 |
| March 31, 2021 | 0.2844 |
| December 31, 2020 | 0.3411 |
| September 30, 2020 | 0.367 |
| June 30, 2020 | 0.1716 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1553 |
| December 31, 2019 | 0.2252 |
| September 30, 2019 | 0.2544 |
| June 30, 2019 | 0.2284 |
| March 31, 2019 | 0.1739 |
| December 31, 2018 | 0.2986 |
| September 30, 2018 | 0.2126 |
| June 30, 2018 | 0.43 |
| March 31, 2018 | 0.19 |
| December 31, 2017 | 0.21 |
| September 30, 2017 | 0.25 |
| June 30, 2017 | 0.23 |
| March 31, 2017 | 0.16 |
| December 31, 2016 | 0.13 |
| September 30, 2016 | 0.17 |
| June 30, 2016 | 0.14 |
| March 31, 2016 | 0.11 |
| December 31, 2015 | 0.13 |
| September 30, 2015 | 0.11 |
| June 30, 2015 | 0.10 |
| March 31, 2015 | 0.08 |
| December 31, 2014 | 0.11 |
| September 30, 2014 | 0.05 |
| June 30, 2014 | 0.08 |
| March 31, 2014 | -0.01 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.615 |
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.05M |
| Revenue (Quarterly) | 70.38M |
| Total Expenses (Quarterly) | 53.33M |
| Enterprise Value | 1.642B |
| Gross Profit Margin (Quarterly) | 70.12% |
| Profit Margin (Quarterly) | 24.22% |
| Earnings Yield | 3.51% |
| Operating Earnings Yield | 4.07% |
| Normalized Earnings Yield | 3.508 |